Correlation Between ProMIS Neurosciences and Enliven Therapeutics

Can any of the company-specific risk be diversified away by investing in both ProMIS Neurosciences and Enliven Therapeutics at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining ProMIS Neurosciences and Enliven Therapeutics into the same portfolio, which is an essential part of the fundamental portfolio management process.

By analyzing existing cross correlation between ProMIS Neurosciences and Enliven Therapeutics, you can compare the effects of market volatilities on ProMIS Neurosciences and Enliven Therapeutics and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in ProMIS Neurosciences with a short position of Enliven Therapeutics. Check out your portfolio center. Please also check ongoing floating volatility patterns of ProMIS Neurosciences and Enliven Therapeutics.

Diversification Opportunities for ProMIS Neurosciences and Enliven Therapeutics

0.44

Correlation Coefficient

ProMIS Neurosciences  Enliven Therapeutics

Very weak diversification

The 3 months correlation between ProMIS and Enliven is 0.44. Overlapping area represents the amount of risk that can be diversified away by holding ProMIS Neurosciences and Enliven Therapeutics in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Enliven Therapeutics and ProMIS Neurosciences is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on ProMIS Neurosciences are associated (or correlated) with Enliven Therapeutics. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Enliven Therapeutics has no effect on the direction of ProMIS Neurosciences i.e., ProMIS Neurosciences and Enliven Therapeutics go up and down completely randomly.

Pair Corralation between ProMIS Neurosciences and Enliven Therapeutics

Considering the 90-day investment horizon ProMIS Neurosciences is expected to under-perform the Enliven Therapeutics. In addition to that, ProMIS Neurosciences is 1.26 times more volatile than Enliven Therapeutics. It trades about -0.06 of its total potential returns per unit of risk. Enliven Therapeutics is currently generating about -0.05 per unit of volatility. If you would invest  2,287  in Enliven Therapeutics on December 19, 2024 and sell it today you would lose (259.00) from holding Enliven Therapeutics or give up 11.32% of portfolio value over 90 days.

Time Period	3 Months [change]
Direction	Moves Together
Strength	Weak
Accuracy	98.33%
Values	Daily Returns

ProMIS Neurosciences  vs.  Enliven Therapeutics

ProMIS Neurosciences

Risk-Adjusted Performance

Very Weak

Over the last 90 days ProMIS Neurosciences has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of fragile performance in the last few months, the Stock's primary indicators remain very healthy which may send shares a bit higher in April 2025. The recent disarray may also be a sign of long period up-swing for the firm investors.

Enliven Therapeutics

Risk-Adjusted Performance

Very Weak

Over the last 90 days Enliven Therapeutics has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of latest weak performance, the Stock's basic indicators remain healthy and the recent disarray on Wall Street may also be a sign of long period gains for the firm investors.

Pair Trading with ProMIS Neurosciences and Enliven Therapeutics

The main advantage of trading using opposite ProMIS Neurosciences and Enliven Therapeutics positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if ProMIS Neurosciences position performs unexpectedly, Enliven Therapeutics can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Enliven Therapeutics will offset losses from the drop in Enliven Therapeutics' long position.

The idea behind ProMIS Neurosciences and Enliven Therapeutics pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.

Check out your portfolio center.

Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Portfolio Volatility module to check portfolio volatility and analyze historical return density to properly model market risk.